A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures
Biton, Victor, Krauss, Gregory, Vasquez‐Santana, Blanca, Bibbiani, Francesco, Mann, Allison, Perdomo, Carlos, Narurkar, Milind
Published in Epilepsia (Copenhagen) (01.02.2011)
Published in Epilepsia (Copenhagen) (01.02.2011)
Get full text
Journal Article
Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects
Critchley, David John, PhD, Aluri, Jagadeesh, MS, Boyd, Peter, MSc, Whayman, Matthew, MSc, Narurkar, Milind, PhD, Delargy, Hugh, PhD, Bibbiani, Francesco, MD
Published in Clinical therapeutics (2011)
Published in Clinical therapeutics (2011)
Get full text
Journal Article
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures
Elger, Christian E, Stefan, Hermann, Mann, Allison, Narurkar, Milind, Sun, Yijun, Perdomo, Carlos
Published in Epilepsy research (01.02.2010)
Published in Epilepsy research (01.02.2010)
Get full text
Journal Article
Mass balance study of TAS-102 using 14 C labeling analyzed by accelerator mass spectrometry
Lee, James J., Seraj, Jabed, Yoshida, Kenichiro, Narurkar, Milind, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Pollice, Laura, Mason, Scott, Sun, Weijing, Chu, Edward, Croft, Marie, Nguteren, James, Tedder, Charles, Beumer, Jan Hendrik
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, FourPeriod, Four-Sequence Crossover Study in Healthy Subjects
CRITCHLEY, David John, ALURI, Jagadeesh, BOYD, Peter, WHAYMAN, Matthew, NARURKAR, Milind, DELARGY, Hugh, BIBBIANI, Francesco
Published in Clinical therapeutics (2011)
Get full text
Published in Clinical therapeutics (2011)
Journal Article
Rufinamide from clinical trials to clinical practice in the United States and Europe
Resnick, Trevor, Arzimanoglou, Alexis, Brown, Lawrence W, Flamini, Robert, Kerr, Michael, Kluger, Gerhard, Kothare, Sanjeev, Philip, Sunny, Harrison, Miranda, Narurkar, Milind
Published in Epileptic disorders (01.05.2011)
Published in Epileptic disorders (01.05.2011)
Get full text
Journal Article
Rufinamide from clinical trials to clinical practice in the United States and Europe
Resnick, Trevor, Arzimanoglou, Alexis, Brown, Lawrence W, Flamini, Robert, Kerr, Michael, Kluger, Gerhard, Kothare, Sanjeev, Philip, Sunny, Harrison, Miranda, Narurkar, Milind
Published in Epileptic disorders (01.03.2011)
Get full text
Published in Epileptic disorders (01.03.2011)
Journal Article
Safety, Pharmacokinetics (PK), Metabolism, and Mass Balance of [14C]-AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl Tyrosine Kinase, in Healthy Subjects
Kagan, Mark, Tran, Phi, Fischer, Volker, Savage, Paula, Smith, Tom, Tanaka, Chiaki, Schran, Horst, Narurkar, Milind, Alland, Leila
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen
Tammara, V K, Narurkar, M M, Crider, A M, Khan, M A
Published in Pharmaceutical research (01.08.1993)
Published in Pharmaceutical research (01.08.1993)
Get more information
Journal Article
MORPHOLINOALKYL ESTER PRODRUGS OF DICLOFENAC - SYNTHESIS, IN-VITRO AND IN-VIVO EVALUATION
TAMMARA, VK, NARURKAR, MM, CRIDER, AM, KHAN, MA
Published in Journal of pharmaceutical sciences (01.05.1994)
Published in Journal of pharmaceutical sciences (01.05.1994)
Get more information
Journal Article